HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: Analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years

References

• Etoh K, Yamaguchi K, Tokudome S, Watanabe T, Okayama A, Stuver S, Mueller N, Takatsuki K, Matsuoka M (1999). Rapid quantification of HTLV-I provirus load: detec-tion of monoclonal proliferation of HTLV-I-infected cells among blood donors. Intl Cancer 81: 859–864.
   Google Scholar
• Gessain A, Saal F, Gout O, Daniel MT, Flandrin G, de The G, Peries J, Sigaux F (1990). High human T-cell lym-photropic virus type I proviral DNA load with poly-clonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African pa-tients with tropical spastic paraparesis. Blood 75: 428–433.
   PubMed Web of Science ®Google Scholar
• Gessain A, Saal F, Gout O, Daniel MT, Flandrin G, de The G, Peries J, Sigaux F (1990). High human T-cell lym-photropic virus type I proviral DNA load with poly-clonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African pa-tients with tropical spastic paraparesis. Blood 75: 428–433.
   PubMed Web of Science ®Google Scholar
• Gessain A, Gout 0 (1992). Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 117: 933–946.
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Higuchi I, Osame M, Izumo S (1998). Quan-titative in situ PCR assay of HTLV-1 infected cells in peripheral blood lymphocytes of patients with ATL, HAM/TSP and asymptomatic carriers. J Neurol Sci 159: 67–72.
   PubMed Web of Science ®Google Scholar
• Ijichi S, Nakagawa M, Umehara F, Higuchi I, Arimura K, Izumo S, Osame M (1996). HAM/TSP: recent perspec-tives in Japan. J Acquir Immune Defic Syndr Hum Retro-virol 13\(Suppl 1): S26–S32.
   Google Scholar
• Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, Bunce M, Ogg GS, Welsh KI, Weber JN, Lloyd AL, Nowak MA, Nagai M, Kodama D, Izumo S, Osame M, Bangham CR (1999). HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Nat] Acad Sci USA 96: 3848–3853.
   Google Scholar
• Kaplan JE, Osame M, Kubota H, Igata A, Nishitani H, Maeda Y, Khabbaz RF, Janssen RS (1990). The risk of develop-ment of HTLV-I- associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. I Ac-quir Immune Defic Syndr 3: 1096–1101.
   PubMed Web of Science ®Google Scholar
• Kira J, Koyanagi Y, Yamada T, Itoyama Y, Goto I, Yamamoto N, Sasaki H, Sakaki Y (1991). Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study. Ann Neurol 29: 194–201.
   Google Scholar
• Kubota R, Fujiyoshi T, Izumo S, Yashiki S, Maruyama I, Osame M, Sonoda S (1993). Fluctuation of HTLV-I provi-ral DNA in peripher al blo o d mononuclear cells of HTLV-I-associated myelopathy. I Neuroimmunol 42: 147–154.
   Google Scholar
• Kubota R, Umehara F, Izumo S, Ijichi S, Matsumuro K, Yashiki S, Fujiyoshi T, Sonoda S, Osame M (1994). HTLV-I proviral DNA amount correlates with infiltrat-ing CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. I Neuroimmunol 53: 23–29.
   Google Scholar
• Lehky TJ, Levin MC, Kubota R, Bamford RN, Flerlage AN, Soldan SS, Leist TP, Xavier A, White JD, Brown M, Fleisher TA, Top LE, Light S, McFarland HF, Waldmann TA, Jacobson S (1998). Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis pa-tients treated with humanized anti-Tac. Ann Neurol 44: 942–947.
   PubMed Web of Science ®Google Scholar
• Matsuoka E, Takenouchi N, Hashimoto K, Kashio N, Moritoyo T, Higuchi I, Isashiki Y, Sato E, Osame M, Izumo S (1998). Perivascular T cells are infected with HTLV-I in the spinal cord lesions with HTLV-I-associated myelopathy/tropical spastic paraparesis: double staining of immunohistochemistry and poly-merase chain reaction in situ hybridization. Acta Neu-ropathol (Berl) 96: 340–346.
   Google Scholar
• Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S, Osame M (1998). Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 4: 586–593.
   Google Scholar
• Nakagawa M, Izumo S, Ijichi S, Kubota H, Arimura K, Kawabata M, Osame M (1995). HTLV-I-associated myelopathy: Analysis of 213 patients based on clin-ical features and laboratory findings. I Neurovirol 1: 50–61.
   Google Scholar
• Nakagawa M, Nakahara K, Maruyama Y, Kawabata M, Higuchi I, Kubota H, Izumo S, Arimura K, Osame M (1996). Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. I Neurovirol 2: 345–355.
   Google Scholar
• Ono A, Ikeda E, Mochizuki M, Matsuoka M, Yamaguchi K, Sawada T, Yamane S, Tokudome S, Watanabe T (1998). Provirus load in patients with human T-cell leukemia virus type 1 uveitis correlates with precedent Graves' disease and disease activities. Jpn J Cancer Res 89: 608–614.
   PubMedGoogle Scholar
• Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, Igata A (1987). Chronic progres-sive myelopathy associated with elevated antibodies to HTLV-I and adult T-cell leukemia-like cells. Ann Neurol 21: 117–122.
   PubMed Web of Science ®Google Scholar
• Osame M, McArthur JC (1992). Neurological manifesta-tions of infection with human T cell lymphotropic virus type I. In: Diseases of the nervous system: clini-cal neurobiology. Asbury AK, McKhann GM, McDonald IW (eds). 2nd ed. Vol 2, WB Saunders: Philadelphia, pp 1331-1339.
   Google Scholar
• Taylor GP, Hall SE, Navarrete S, Michie CA, Davis R, Witkover AD, Rossor M, Nowak MA, Rudge P, Matutes E, Bangham CR, Weber JN (1999). Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopa-thy. I Virol 73: 10289–10295.
   PubMed Web of Science ®Google Scholar
• Umehara F, Izumo S, Nakagawa M, Ronquillo AT, Takahashi K, Matsumuro K, Sato E, Osame M (1993). Im-munocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopa-thy. J Neuropathol Exp Neurol 52: 424–430.
   Google Scholar
• Ureta-Vidal A, Angelin-Duclos C, Tortevoye P, Murphy E, Lepere JF, Buigues RP, Jolly N, Joubert M, Carles G, Pouliquen JF, de The G, Moreau JP, Gessain A (1999). Mother-to-child transmission of human T-cell-leukemia/lymphoma virus type I: implication of high antiviral antibody titer and high proviral load in carrier mothers. Intl Cancer 82: 832–836.
   Google Scholar
• Usuku K, Sonoda S, Osame M, Yashiki S, Takahashi K, Matsumoto M, Sawada T, Tsuji K, Tara M, Igata A (1988). HLA haplotype-linked high immune responsive-ness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann Neurol 23 (Suppl): S143–S150.
   Google Scholar
• Wattel E, Mariotti M, Agis F, Gordien E, Le Coeur FF, Prin L, Rouger P, Chen IS, Wain-Hobson S, Lefrere JJ (1992). Quantification of HTLV-1 proviral copy number in pe-ripheral blood of symptomless carriers from the French West Indies. J Acquir Immune Defic Syndr 5: 943–946.
   Google Scholar
• Yoshida M, Osame M, Kawai H, Toita M, Kuwasaki N, Nishida Y, Hiraki Y, Takahashi K, Nomura K, Sonoda S, et al (1989). Increased replication of HTLV-I in HTLV-I-ass oc iate d myelopathy. Ann Neurol 26: 331–335.
   PubMed Web of Science ®Google Scholar